Catalyst Wire Dossier Catalyst Wire Dossier

IDegLira

insulin degludec/liraglutide · Novo Nordisk
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for IDegLira, covering 2017-05-23 to 2024-05-10. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes [Phase 4]

See pricing